Cell Source, Inc. Note Agreements

29 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Original Issue Date: January 27, 2015$250,000.00 CONVERTIBLE NOTE DUE JULY 27, 2016
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2016
Original Issue Discount Note issued to Helen Samuels Investment ULC
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2024
Original Issue Discount Note issued to Honey Kamenetsky Investment ULC
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2024
Original Issue Discount Note issued to Phyllis Friedman Investment ULC
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2024
Original Issue Discount Note issued to Solomon Zolty Investment ULC
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2024
Original Issue Discount Note issued to David Zolty Investment ULC
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2024
Original Issue Discount Note issued to Darlene Soave Revocable Trust
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2024
Amendment No. 2 to 10% Convertible Note
Note Agreements
Cell Source, Inc.
Biotechnology
2023
Amendment No. 4 to Third Amended and Restated Note
Note Agreements
Cell Source, Inc.
Biotechnology
2023
Amendment No. 1 to10% Convertible Note
Note Agreements
Cell Source, Inc.
Biotechnology
2023
Amendment No. 3 to Third Amended and Restated Note
Note Agreements
Cell Source, Inc.
Biotechnology
2023
Amendment No. 2 to Third Amended and Restated Note
Note Agreements
Cell Source, Inc.
Biotechnology
2023
Amendment No. 1 to Third Amended and Restated Note
Note Agreements
Cell Source, Inc.
Biotechnology
2023
10% Convertible Note issued to George Verstraete
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2022
Third Amended and Restated 10.0% Convertible Note
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2021
Second Amended and Restated 10.0% Convertible Note
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2021
Form of 8% Convertible Promissory Note
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2020
Form of 10% OID Convertible Promissory Note
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2020
Form of Securities Purchase Agreement between Cell Source, Inc. and the purchaser of 10% OID Convertible Promissory Note
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2020
Convertible Promissory Note dated January 10, 2020
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2020
Convertible Note effective October 28, 2019
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2020
PROMISSORY NOTE
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2016
PROMISSORY NOTE OF CELL SOURCE, INC.
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2016
CONVERTIBLE NOTE DUE [*], 20[*]
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2016
CONVERTIBLE PROMISSORY NOTE OF CELL SOURCE, INC.
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2015
PROMISSORY NOTE OF CELL SOURCE, INC.
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2015
PROMISSORY NOTE OF CELL SOURCE, INC.
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2015
PROMISSORY NOTE OF CELL SOURCE, INC.
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2015
PROMISSORY NOTE
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2014